The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.

Toni Portis*, Lori Cooper, Patrick Dennis, Richard Longnecker

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

INIS